Oric Pharmaceuticals, Inc. (ORIC) SEC Filings — 2024
27 SEC filings for Oric Pharmaceuticals, Inc. (ORIC) in 2024.
Filings
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 14, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 13, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Nov 12, 2024
- Oric Pharmaceuticals Files Q3 2024 10-Q — 10-Q · Nov 12, 2024
- Oric Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Nov 8, 2024
- Oric Pharmaceuticals, Inc. SC 13G Filing — SC 13G · Oct 22, 2024
- Oric Pharmaceuticals Files Q2 2024 10-Q — 10-Q · Aug 12, 2024
- Oric Pharmaceuticals Reports on Shareholder Vote — 8-K · Jun 14, 2024
- Oric Pharmaceuticals Files 10-Q for Period Ending March 31, 2024 — 10-Q · May 6, 2024
- Oric Pharmaceuticals Announces 2024 Annual Meeting of Stockholders — DEF 14A · Apr 24, 2024
- Oric Pharmaceuticals Appoints New CEO, CMO, COO — 8-K · Mar 29, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Mar 11, 2024
- Oric Pharmaceuticals Files 2023 Annual Report on Form 10-K — 10-K · Mar 11, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 14, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- Oric Pharmaceuticals, Inc. SC 13G/A Filing — SC 13G/A · Feb 13, 2024
- FMR LLC & Abigail Johnson Maintain 12.835% Stake in Oric Pharma — SC 13G/A · Feb 9, 2024
- BlackRock Amends Oric Pharma Stake as of Jan 31 — SC 13G/A · Feb 7, 2024
- Millennium Management Amends Oric Pharma Stake on Dec 31, 2023 — SC 13G/A · Feb 6, 2024
- Venrock Healthcare Capital Partners Discloses Passive Stake in Oric Pharma — SC 13G · Feb 1, 2024
- Viking Global Discloses Significant Stake in Oric Pharma (ORIC) — SC 13G · Jan 30, 2024
- BlackRock Discloses Passive Stake in Oric Pharmaceuticals — SC 13G · Jan 29, 2024
- Frazier Life Sciences Discloses 9.9% Passive Stake in Oric Pharma — SC 13G · Jan 25, 2024
- ORIC Pharma Enters Material Agreement, Sells Unregistered Equity — 8-K · Jan 22, 2024
- ORIC Pharma Files 8-K on Operations & Financial Condition — 8-K · Jan 9, 2024